RUNX1T1 and retinoblastoma: Furthermore, inhibition of miR-184 expression was rapid, starting at day 1 on exposure of Y79 (Figure 1D) and WERI cells (Figure 1E) in culture to vincristine (VCR), ETO, and carboplatin (CBP), which are agents commonly used systemically in RB treatment.